Efficacy and Safety Study With MYL-1401H and Neulasta

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and Safety Study of MYL-1401H and Neulasta (Pegfilgrastim) in Stage II/III Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy.
Epistemonikos ID: af16ab6d88b30831811fc6da81a13a8e88cec4aa
First added on: May 12, 2024